✦ LIBER ✦

The discovery and status of sibutramine as an anti-obesity drug

✍ Scribed by Carla A. Luque; Jose A. Rey

Book ID: 114014646
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 128 KB
Volume: 440
Category: Article
ISSN: 0014-2999
DOI: 10.1016/s0014-2999(02)01423-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety Assessment of an Anti-Obesity Dru

Safety Assessment of an Anti-Obesity Drug (Sibutramine)

✍ Jerzy E. Tyczynski, Dr Denise M. Oleske, David Klingman, Cheryl P. Ferrufino, Wo 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 191 KB

Orlistat: its current status as an anti-

Orlistat: its current status as an anti-obesity drug

✍ Anne Ballinger; Steven R Peikin 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 136 KB

PYY3-36 as an anti-obesity drug target

✍ M. M. Boggiano; P. C. Chandler; K. D. Oswald; R. J. Rodgers; J. E. Blundell; Y. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Neuropeptide Y receptors as targets for

Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status

✍ Eric Parker; Margaret Van Heek; Andrew Stamford 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 209 KB

The stereoselective biotransformation of

The stereoselective biotransformation of the anti-obesity drug sibutramine in rat liver microsomes and in primary cultures of rat hepatocytes

✍ Marek Link; Romana Novotná; Bohumila Suchanová; Lenka Skálová; Vladimír Wsól; Ba 📂 Article 📅 2005 🏛 Pharmaceutical Press 🌐 English ⚖ 161 KB

Use of sibutramine and other noradrenerg

Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity

✍ Donna H. Ryan 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 100 KB